{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:16:55Z","timestamp":1779106615104,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470199"],"award-info":[{"award-number":["82470199"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570253"],"award-info":[{"award-number":["82570253"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270211"],"award-info":[{"award-number":["82270211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270197"],"award-info":[{"award-number":["82270197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019643","name":"State Key Laboratory of Radiation Medicine and Protection","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014883","name":"China National Nuclear Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007824","name":"Soochow University","doi-asserted-by":"publisher","award":["GZK12023020"],"award-info":[{"award-number":["GZK12023020"]}],"id":[{"id":"10.13039\/501100007824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007824","name":"Soochow University","doi-asserted-by":"publisher","award":["GZK12024014"],"award-info":[{"award-number":["GZK12024014"]}],"id":[{"id":"10.13039\/501100007824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014358","name":"Second Affiliated Hospital of Soochow University","doi-asserted-by":"publisher","award":["SDFEYHT2324"],"award-info":[{"award-number":["SDFEYHT2324"]}],"id":[{"id":"10.13039\/501100014358","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.colsurfb.2026.115598","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:53:46Z","timestamp":1773302026000},"page":"115598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Milk exosomes delivery of KPT-330 alleviates gastrointestinal adverse reactions and provides effective anti-diffuse large B-cell lymphoma therapy"],"prefix":"10.1016","volume":"264","author":[{"given":"Yali","family":"Chai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingming","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lexin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meifang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxia","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingzong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8552-991X","authenticated-orcid":false,"given":"Wenzhuo","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2026.115598_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ctrv.2018.01.002","article-title":"Targeting the b-cell receptor pathway in diffuse large b-cell lymphoma","volume":"65","author":"Dunleavy","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.colsurfb.2026.115598_bib2","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the lnh-98.5 trial, the first randomized study comparing rituximab-chop to standard chop chemotherapy in dlbcl patients: a study by the groupe d\u2032etudes des lymphomes de l\u2032adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.colsurfb.2026.115598_bib3","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1038\/s41375-021-01285-3","article-title":"Treatment resistance in diffuse large b-cell lymphoma","volume":"35","author":"He","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.colsurfb.2026.115598_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1158\/0008-5472.CAN-23-1992","article-title":"Xpo1 enables adaptive regulation of mrna export required for genotoxic stress tolerance in cancer cells","volume":"84","author":"Marullo","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.colsurfb.2026.115598_bib5","doi-asserted-by":"crossref","first-page":"e511","DOI":"10.1016\/S2352-3026(20)30120-4","article-title":"Selinexor in patients with relapsed or refractory diffuse large b-cell lymphoma (sadal): a single-arm, multinational, multicentre, open-label, phase 2 trial","volume":"7","author":"Kalakonda","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.colsurfb.2026.115598_bib6","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/386779a0","article-title":"Nucleocytoplasmic transport: signals, mechanisms and regulation","volume":"386","author":"Nigg","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2026.115598_bib7","unstructured":"2019, FDA CfDEaRC. Nda\/bla multi-discipline reviewevaluation: Xpovio\u00ae (selinexor)."},{"key":"10.1016\/j.colsurfb.2026.115598_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/13543784.2020.1706087","article-title":"Selinexor (ktp-330) - a selective inhibitor of nuclear export (sine): Anti-tumor activity in diffuse large b-cell lymphoma (dlbcl)","volume":"29","author":"Ben-Barouch","year":"2020","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.colsurfb.2026.115598_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100758","article-title":"Selinexor, selective inhibitor of nuclear export: unselective bullet for blood cancers","volume":"46","author":"Benkova","year":"2021","journal-title":"Blood Rev."},{"key":"10.1016\/j.colsurfb.2026.115598_bib10","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.2147\/IJN.S281890","article-title":"Advances in exosome-based drug delivery and tumor targeting: from tissue distribution to intracellular fate","volume":"15","author":"Shao","year":"2020","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.colsurfb.2026.115598_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbalip.2013.10.004","article-title":"Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies","volume":"1841","author":"Record","year":"2014","journal-title":"Biochim. Et. Biophys. Acta"},{"key":"10.1016\/j.colsurfb.2026.115598_bib12","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.biocel.2012.08.007","article-title":"Exosomes: new players in cell-cell communication","volume":"44","author":"Bang","year":"2012","journal-title":"Int. J. Biochem. & Cell Biol."},{"key":"10.1016\/j.colsurfb.2026.115598_bib13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jconrel.2015.07.030","article-title":"Using exosomes, naturally-equipped nanocarriers, for drug delivery","volume":"219","author":"Batrakova","year":"2015","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.colsurfb.2026.115598_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jconrel.2025.01.090","article-title":"Modulating the elasticity of milk exosome-based hybrid vesicles to optimize transepithelial transport and enhance oral peptide delivery","volume":"380","author":"Xiao","year":"2025","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.colsurfb.2026.115598_bib15","doi-asserted-by":"crossref","first-page":"21091","DOI":"10.1021\/acsnano.4c02560","article-title":"Milk exosome-liposome hybrid vesicles with self-adapting surface properties overcome the sequential absorption barriers for oral delivery of peptides","volume":"18","author":"Xiao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2026.115598_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700082","article-title":"Human milk exosomes and their micrornas survive digestion in vitro and are taken up by human intestinal cells","volume":"61","author":"Liao","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.colsurfb.2026.115598_bib17","doi-asserted-by":"crossref","first-page":"e43691","DOI":"10.1371\/journal.pone.0043691","article-title":"Lactation-related microrna expression profiles of porcine breast milk exosomes","volume":"7","author":"Gu","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.colsurfb.2026.115598_bib18","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.apsb.2021.12.015","article-title":"Milk-derived exosomes exhibit versatile effects for improved oral drug delivery","volume":"12","author":"Wu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.colsurfb.2026.115598_bib19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s12010-017-2478-4","article-title":"Curcumin encapsulated in milk exosomes resists human digestion and possesses enhanced intestinal permeability in vitro","volume":"183","author":"Vashisht","year":"2017","journal-title":"Appl. Biochem Biotechnol."},{"key":"10.1016\/j.colsurfb.2026.115598_bib20","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1039\/C7FO00882A","article-title":"Exosomal delivery of berry anthocyanidins for the management of ovarian cancer","volume":"8","author":"Aqil","year":"2017","journal-title":"Food & Funct."},{"key":"10.1016\/j.colsurfb.2026.115598_bib21","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.nano.2017.03.001","article-title":"Milk-derived exosomes for oral delivery of paclitaxel","volume":"13","author":"Agrawal","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.colsurfb.2026.115598_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700009","article-title":"Characterization and biological function of milk-derived mirnas","volume":"61","author":"Golan-Gerstl","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.colsurfb.2026.115598_bib23","doi-asserted-by":"crossref","first-page":"e0121123","DOI":"10.1371\/journal.pone.0121123","article-title":"Commercial cow milk contains physically stable extracellular vesicles expressing immunoregulatory tgf-b","volume":"10","author":"Pieters","year":"2015","journal-title":"eta. PloS One"},{"key":"10.1016\/j.colsurfb.2026.115598_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14227\/DT180311P15","article-title":"Simulated biological fluids with possible application in dissolution testing","volume":"18","author":"Marques","year":"2011","journal-title":"Dissol. Technol."},{"key":"10.1016\/j.colsurfb.2026.115598_bib25","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1021\/acs.molpharmaceut.3c00746","article-title":"Long-acting nanohybrid hydrogel induces persistent immunogenic chemotherapy for suppressing postoperative tumor recurrence and metastasis","volume":"20","author":"Li","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115598_bib26","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1161\/STROKEAHA.114.005427","article-title":"Cell-culture models of the blood-brain barrier","volume":"45","author":"He","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.colsurfb.2026.115598_bib27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1109\/TNB.2021.3097909","article-title":"Modeling of anti-cancer drug release kinetics from liposomes and micelles: a review","volume":"20","author":"Sawaftah","year":"2021","journal-title":"IEEE Trans. Nanobiosci."},{"key":"10.1016\/j.colsurfb.2026.115598_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13045-020-00982-3","article-title":"Xpo1 expression worsens the prognosis of unfavorable dlbcl that can be effectively targeted by selinexor in the absence of mutant p53","volume":"13","author":"Deng","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.colsurfb.2026.115598_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biom13010111","article-title":"Nuclear export in non-hodgkin lymphoma and implications for targeted xpo1 inhibitors","volume":"13","author":"Trkulja","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.colsurfb.2026.115598_bib30","article-title":"Routes and mechanisms of extracellular vesicle uptake","volume":"3","author":"Mulcahy","year":"2014","journal-title":"J. Extra Vesicles"},{"key":"10.1016\/j.colsurfb.2026.115598_bib31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jconrel.2015.09.031","article-title":"Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of paclitaxel in autologous prostate cancer cells","volume":"220","author":"Saari","year":"2015","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.colsurfb.2026.115598_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.colsurfb.2026.115598_bib33","first-page":"1151","article-title":"Vitreoretinal presentation of secondary large b-cell lymphoma in patients with systemic lymphoma","volume":"131","author":"Salom?O","year":"2013","journal-title":"ALJJO"},{"key":"10.1016\/j.colsurfb.2026.115598_bib34","first-page":"e511","article-title":"Selinexor in patients with relapsed or refractory diffuse large b-cell lymphoma (sadal): a single-arm, multinational, multicentre, open-label, phase 2 trial","volume":"7","author":"Kalakonda","year":"2020"},{"key":"10.1016\/j.colsurfb.2026.115598_bib35","first-page":"577","article-title":"Selinexor: a first-in-class nuclear export inhibitor for management of multiply relapsed multiple myeloma","volume":"54","author":"Peterson","year":"2020","journal-title":"Ann. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115598_bib36","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/onco.13859","article-title":"Fda approval summary: selinexor for relapsed or refractory diffuse large b-cell lymphoma","volume":"26","author":"Kasamon","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.colsurfb.2026.115598_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9798-5_1","article-title":"An overview of drug delivery systems","volume":"2059","author":"Jain","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.colsurfb.2026.115598_bib38","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/nprot.2012.131","article-title":"Exosome-mediated delivery of sirna in vitro and in vivo","volume":"7","author":"El-Andaloussi","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.colsurfb.2026.115598_bib39","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1039\/D2FO02013K","article-title":"Milk exosomes: an oral drug delivery system with great application potential","volume":"14","author":"Tian","year":"2023","journal-title":"Food & Funct."},{"key":"10.1016\/j.colsurfb.2026.115598_bib40","article-title":"Milk-derived exosomes as a promising vehicle for oral delivery of hydrophilic biomacromolecule drugs","volume":"18","author":"Li","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2026.115598_bib41","doi-asserted-by":"crossref","first-page":"e0170628","DOI":"10.1371\/journal.pone.0170628","article-title":"A comparative study of serum exosome isolation using differential ultracentrifugation and three commercial reagents","volume":"12","author":"Helwa","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.colsurfb.2026.115598_bib42","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1021\/acs.nanolett.0c00929","article-title":"Transplantation of human mesenchymal stem-cell-derived exosomes immobilized in an adhesive hydrogel for effective treatment of spinal cord injury","volume":"20","author":"Li","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.colsurfb.2026.115598_bib43","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2147\/DDDT.S112039","article-title":"Novel curcumin-loaded human serum albumin nanoparticles surface functionalized with folate: characterization and in vitro\/vivo evaluation","volume":"10","author":"Song","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.colsurfb.2026.115598_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8850820","article-title":"Mesenchymal stem cells enhance therapeutic effect and prevent adverse gastrointestinal reaction of methotrexate treatment in collagen-induced arthritis","volume":"2021","author":"Zhai","year":"2021","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.colsurfb.2026.115598_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000507626","article-title":"Milk exosomes prevent intestinal inflammation in a genetic mouse model of ulcerative colitis: a pilot experiment","volume":"5","author":"Stremmel","year":"2020","journal-title":"Inflamm. Intest. Dis."},{"key":"10.1016\/j.colsurfb.2026.115598_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/nu12092589","article-title":"Cow and human milk-derived exosomes ameliorate colitis in dss murine model","volume":"12","author":"Reif","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.colsurfb.2026.115598_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121126","article-title":"High-quality milk exosomes as oral drug delivery system","volume":"277","author":"Zhong","year":"2021","journal-title":"Biomaterials"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526001864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526001864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:53:37Z","timestamp":1779105217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526001864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":47,"alternative-id":["S0927776526001864"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115598","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Milk exosomes delivery of KPT-330 alleviates gastrointestinal adverse reactions and provides effective anti-diffuse large B-cell lymphoma therapy","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115598"}}